Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-02-06T06:24:14.250Z Has data issue: false hasContentIssue false

Transgenic models of the transmissible spongiform encephalopathies

Published online by Cambridge University Press:  12 February 2004

Jean C. Manson
Affiliation:
Institute for Animal Health, Neuropathogenesis Unit, Ogston Building, West Mains Road, Edinburgh, EH9 3JF, UK.
Nadia L. Tuzi
Affiliation:
Institute for Animal Health, Neuropathogenesis Unit, Ogston Building, West Mains Road, Edinburgh, EH9 3JF, UK.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The transmissible spongiform encephalopathies (TSEs) are a group of fatal neurodegenerative diseases that are also transmissible. The PrP protein is central to the disease process and has been hypothesised to be the infectious agent. Polymorphisms in the PrP gene have been linked to the incubation time of TSE disease, and mutations in the human PrP gene have been suggested to result in genetic TSE disease. Several PrP transgenic models have been developed. These models express PrP from different species, with and without PrP mutations, and at different levels of gene expression. This article discusses the contribution of these transgenic models to our present understanding of the TSE diseases.

Type
Review Article
Copyright
© Cambridge University Press 2001